Your browser doesn't support javascript.
loading
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.
Borisov, Sergey; Danila, Edvardas; Maryandyshev, Andrei; Dalcolmo, Margareth; Miliauskas, Skaidrius; Kuksa, Liga; Manga, Selene; Skrahina, Alena; Diktanas, Saulius; Codecasa, Luigi Ruffo; Aleksa, Alena; Bruchfeld, Judith; Koleva, Antoniya; Piubello, Alberto; Udwadia, Zarir Farokh; Akkerman, Onno W; Belilovski, Evgeny; Bernal, Enrique; Boeree, Martin J; Cadiñanos Loidi, Julen; Cai, Qingshan; Cebrian Gallardo, Jose Joaquín; Dara, Masoud; Davidaviciene, Edita; Forsman, Lina Davies; De Los Rios, Jorge; Denholm, Justin; Draksiene, Jacinta; Duarte, Raquel; Elamin, Seifeldin Eltaeb; Escobar Salinas, Nadia; Ferrarese, Maurizio; Filippov, Alexey; Garcia, Ana; García-García, José-María; Gaudiesiute, Ieva; Gavazova, Blagovesta; Gayoso, Regina; Gomez Rosso, Roscio; Gruslys, Vygantas; Gualano, Gina; Hoefsloot, Wouter; Jonsson, Jerker; Khimova, Elena; Kunst, Heinke; Laniado-Laborín, Rafael; Li, Yang; Magis-Escurra, Cecile; Manfrin, Vinicio; Marchese, Valentina.
Afiliação
  • Borisov S; Moscow Research and Clinical Center for TB Control, Moscow Government's Health Department, Moscow, Russian Federation.
  • Danila E; These authors contributed equally.
  • Maryandyshev A; Clinic of Chest Diseases, Immunology and Allergology, Vilnius University Medical Faculty, Centre of Pulmonology and Allergology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Dalcolmo M; Northern State Medical University, Arkhangelsk, Russian Federation.
  • Miliauskas S; Reference Center Hélio Fraga, Fundação Oswaldo Cruz (Fiocruz)/Ministry of Health, Rio de Janeiro, Brazil.
  • Kuksa L; Dept of Pulmonology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Manga S; MDR-TB Dept, Riga East University Hospital for TB and Lung Disease Centre, Riga, Latvia.
  • Skrahina A; Dept of Infectious Diseases, University National San Antonio Abad Cusco, Cusco, Peru.
  • Diktanas S; Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus.
  • Codecasa LR; Tuberculosis Dept, 3rd Tuberculosis Unit, Republican Klaipeda Hospital, Klaipeda, Lithuania.
  • Aleksa A; TB Reference Centre, Villa Marelli Institute, Niguarda Hospital, Milan, Italy.
  • Bruchfeld J; Dept of Phthisiology and Pulmonology, Grodno State Medical University, Grodno, Belarus.
  • Koleva A; Division of Infectious Diseases, Dept of Medicine, Karolinska Institute, Solna, Sweden.
  • Piubello A; Dept of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Udwadia ZF; These authors contributed equally.
  • Akkerman OW; Pulmonology and Physiotherapy Dept, Gabrovo Lung Diseases Hospital, Gabrovo, Bulgaria.
  • Belilovski E; Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France.
  • Bernal E; Tuberculosis Division, Damien Foundation, Niamey, Niger.
  • Boeree MJ; These authors contributed equally.
  • Cadiñanos Loidi J; Dept of Respiratory Medicine, P.D. Hinduja National Hospital and MRC, Mumbai, India.
  • Cai Q; University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Cebrian Gallardo JJ; University of Groningen, University Medical Center Groningen, TB Center Beatrixoord, Haren, The Netherlands.
  • Dara M; These authors contributed equally.
  • Davidaviciene E; Moscow Research and Clinical Center for TB Control, Moscow Government's Health Department, Moscow, Russian Federation.
  • Forsman LD; Unidad de Enfermedades Infecciosas, Hospital General Universitario Reina Sofia, Murcia, Spain.
  • De Los Rios J; Radboud University Medical Center, Center Dekkerswald, Nijmegen, The Netherlands.
  • Denholm J; Internal Medicine Dept, Hospital General de Villalba, Collado Villalba, Spain.
  • Draksiene J; Zhejiang Integrated Traditional and Western Medicine Hospital, Hangzhou, China.
  • Duarte R; Unidad de Neumología, Agencia Sanitaria Costa del Sol, Marbella, Spain.
  • Elamin SE; World Health Organization Regional Office for Europe, Copenhagen, Denmark.
  • Escobar Salinas N; National TB Registry, Public Health Dept, Ministry of Health, Vilnius, Lithuania.
  • Ferrarese M; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Filippov A; Division of Infectious Diseases, Dept of Medicine, Karolinska Institute, Solna, Sweden.
  • Garcia A; Dept of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • García-García JM; Centro de Excelencia de TB "Niño Jesus", Servicio de Neumologia, Hospital Maria Auxiliadora, Lima, Peru.
  • Gaudiesiute I; Victorian Tuberculosis Program, Melbourne Health, Melbourne, Australia.
  • Gavazova B; Dept of Microbiology and Immunology, University of Melbourne, Melbourne, Australia.
  • Gayoso R; These authors contributed equally.
  • Gomez Rosso R; Tuberculosis Dept, 3rd Tuberculosis Unit, Republican Klaipeda Hospital, Klaipeda, Lithuania.
  • Gruslys V; National Reference Centre for MDR-TB, Hospital Centre Vila Nova de Gaia, Dept of Pneumology, Public Health Science and Medical Education Dept, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Gualano G; MDR-TB Department, Abu anga Teaching Hospital, Khartoum, Sudan.
  • Hoefsloot W; Division of Disease Prevention and Control, Dept of Communicable Diseases, National Tuberculosis Control and Elimination Programme, Ministry of Health, Santiago, Chile.
  • Jonsson J; TB Reference Centre, Villa Marelli Institute, Niguarda Hospital, Milan, Italy.
  • Khimova E; Moscow Research and Clinical Center for TB Control, Moscow Government's Health Department, Moscow, Russian Federation.
  • Kunst H; Pulmonology Division, Municipal Hospital F.J. Muñiz, Buenos Aires, Argentina.
  • Laniado-Laborín R; Tuberculosis Research Programme, SEPAR, Barcelona, Spain.
  • Li Y; Dept of Pulmonology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Magis-Escurra C; "Improve the Sustainability of the National TB Programme", Sofia, Bulgaria.
  • Manfrin V; Reference Center Hélio Fraga, Fundação Oswaldo Cruz (Fiocruz)/Ministry of Health, Rio de Janeiro, Brazil.
  • Marchese V; National Institute of Respiratory and Environmental Diseases "Prof. Dr. Juan Max Boettner" Asunción, Paraguay.
Eur Respir J ; 54(6)2019 12.
Article em En | MEDLINE | ID: mdl-31601711

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Antituberculosos Tipo de estudo: Observational_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Respir J Ano de publicação: 2019 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Antituberculosos Tipo de estudo: Observational_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Respir J Ano de publicação: 2019 Tipo de documento: Article País de publicação: Reino Unido